Levomepromazine

左美丙嗪

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameLevomepromazine
Drug Alias Name左旋甲丙嗪Methotrimeprazine甲氧异丁嗪左米丙嗪Tisercin +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsSchizophreniaDepressive DisorderBipolar Disorder +[4] 
Global Approved IndicationsSchizophreniaDepressive DisorderBipolar Disorder +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1957/01/01
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Pharmaceutical Industry Co LtdAmgen Inc
Inactive CompaniesImmunex Corp
Active IndicationsSchizophreniaDepressive DisorderBipolar Disorder +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN05AA02
Related LinksWikipediaDrugBankKEGG